Search results
Results from the WOW.Com Content Network
In genetics, an enhancer is a short (50–1500 bp) region of DNA that can be bound by proteins to increase the likelihood that transcription of a particular gene will occur. [ 1 ] [ 2 ] These proteins are usually referred to as transcription factors .
Enhanceosomes are formed in special cases when these activators cooperatively bind together along the enhancer sequence to create a distinct three-dimensional structure. Each enhanceosome is unique towards its specific enhancer. This assembly is facilitated by energetically favorable protein: protein and protein: DNA interactions. Therefore ...
During fusion, the heart tube is patterned along the anterior/posterior axis for the various regions and chambers of the heart. The surrounding mesocardium degenerates to leave the primitive heart attached only by its arterial and venous ends, which are anatomically fixed to the pharyngeal arches and the septum transversum, respectively.
Enhancers are DNA sequences found in 5′ flanking regions of eukaryotic genes that affect transcription. If a transcription factor binds to an enhancer in a 5′ flanking region, the DNA strand bends in a way that the transcription factor that is bound to the enhancer can also bind the promoter of a gene.
For example, researchers have found a translocation between chromosomes 8 and 22 (in the region containing the p300 gene) in several people with a cancer of blood cells called acute myeloid leukemia (AML). Another translocation, involving chromosomes 11 and 22, has been found in a small number of people who have undergone cancer treatment.
ISL1 is a marker for cardiac progenitors of the secondary heart field (SHF) which includes the right ventricle and the outflow tract. The biological function of ISL1 is demonstrated through ISL1 mutant mice and chick embryos that have altered cell proliferation, survival, and migration of cardiogenic precursors and severe cardiac defects. [8]
A super-enhancer, illustrated in the lower panel of the Figure, is a region of the mammalian genome comprising multiple typical enhancers that is collectively bound by an array of transcription factor proteins to drive transcription of genes involved in cell identity, [3] [4] [5] or of genes involved in cancer. [6]
H3K4me1 fine-tunes the enhancer activity and function rather than controls. [4] H3K4me1 is put down by KMT2C (MLL3) and KMT2D (MLL4) [6] LSD1, and the related LSD2/KDM1B demethylate H3K4me1 and H3K4me2. [7] Marks associated with active gene transcription like H3K4me1 and H3K9me1 have very short half-lives. [8]